FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab - Prabadin Corp

https://prabadinews.com/

Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

Health

September 2, 2025

By AdminPrabadin - 4 days ago

0

The approval of 2 denosumab biosimilars, Bildyos and Bilprevda, enhances access to affordable bone health treatments for patients.

administrator